MyndTec Announces Results of Annual General and Special Meeting of Shareholders
Mississauga, Ontario--(Newsfile Corp. - June 26, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a neurological treatment and rehabilitation medical technology company, announces the voting results from its annual general and special meeting of shareholders (the "Meeting") held on June 18, 2025.The five (5) candidates nominated for election...
Technology, Healthcare and Hospitals, Health
2025-06-26 4:30 PM EDT | MyndTec Inc.
Canadian Institute of Actuaries Announces Alicia Rollo as New Executive Director
Ottawa, Ontario--(Newsfile Corp. - June 26, 2025) - As the Canadian Institute of Actuaries (CIA) looks to the future, it welcomes new leadership, celebrates a legacy of service and shares key milestones in its continued advancement of the actuarial profession in Canada.Alicia Rollo appointed Executive Director, effective July 1, 2025The...
Healthcare and Hospitals, Pharmaceuticals, Health
2025-06-26 12:00 PM EDT | Canadian Institute of Actuaries / FR: Institut canadien des actuaires
L'Institut canadien des actuaires annonce la nomination d'Alicia Rollo au poste de directrice générale
Ottawa, Ontario--(Newsfile Corp. - 26 juin 2025) - Se tournant vers l'avenir, l'Institut canadien des actuaires accueille une nouvelle dirigeante, célèbre un héritage de service et partage des jalons importants de la progression soutenue de la profession actuarielle au Canada.Nomination d'Alicia Rollo au poste de directrice générale à compter du...
Healthcare and Hospitals, Pharmaceuticals, Health
2025-06-26 12:00 PM EDT | Canadian Institute of Actuaries / FR: Institut canadien des actuaires
New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Go into Effect July 1, Unlocking New Opportunities for Envoy Medical
White Bear Lake, Minnesota--(Newsfile Corp. - June 26, 2025) - Envoy Medical, Inc. (NASDAQ: COCH), a revolutionary hearing health company focused on fully implanted hearing devices that leverage the ear's natural anatomy, today announced that five Category III CPT codes for totally implantable active middle ear implants approved by the...
Biotechnology, Healthcare and Hospitals
2025-06-26 8:00 AM EDT | Envoy Medical, Inc.
Medexus Announces Strong Fiscal Year 2025 Results, Including Initial Results from Launch of GRAFAPEX (treosulfan) for Injection in the United States
Fiscal year 2025 revenue of $108.3 million, record net income of $2.2 million, operating income of $8.2 million, and record Adjusted EBITDA* of $20.2 millionUS commercial launch of GRAFAPEX™ executed in February 2025, following swiftly on the FDA's approval in January 2025, with initial indicators supporting Medexus's confidence in the...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-06-25 6:15 PM EDT | Medexus Pharmaceuticals Inc.
Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Clinical Trial to Fifth Dose Escalation Cohort
-Phio's lead clinical siRNA compound PH-762 demonstrates supportive safety profile in fourth cohort, permitting dose escalation in expected final cohortMarlborough, Massachusetts--(Newsfile Corp. - June 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer....
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-06-25 7:45 AM EDT | Phio Pharmaceuticals Corp.
Cosmo Announces Sale of "Digital Trust" in Strategic Portfolio Streamlining Move
Dublin, Ireland--(Newsfile Corp. - June 25, 2025) - Cosmo today announced the signing of an agreement to sell “Digital Trust” to its existing customer Tinexta InfoCert, Europe’s largest Certification Authority and a subsidiary of Tinexta S.p.A., a publicly listed...
Healthcare and Hospitals, Health
2025-06-25 1:06 AM EDT | Cosmo Pharmaceuticals N.V.
LevelJump Announces Revocation of Cease Trade Order; Seeking Reinstatement of Trading On TSX Venture Exchange
Toronto, Ontario--(Newsfile Corp. - June 24, 2025) - LevelJump Healthcare Corp. - (TSXV: JUMP) ("LevelJump" or the "Company") is pleased to announce that, further to its news release of June 23, 2025, the Ontario Securities Commission (the "OSC") has revoked a Failure-to-File Cease Trade Order (the "FFCTO") that had been originally issued by the...
Healthcare and Hospitals, Health
2025-06-24 1:55 PM EDT | LevelJump Healthcare Corp.
RAICES Adopts NewOrg to Strengthen Social Services for Immigrants and Refugees Nationwide
Washington, D.C.--(Newsfile Corp. - June 24, 2025) - NewOrg Management System, Inc., a leading provider of customizable, cloud-based data management solutions for nonprofits and local governments, announced today that RAICES (Refugee and Immigrant Center for Education and Legal Services) has selected and implemented NewOrg's platform to coordinate and enhance its...
Computer Software, Healthcare and Hospitals, Housing, Aboriginal/Indigenous
2025-06-24 12:00 PM EDT | NewOrg Management System Inc
Adia Nutrition Inc. Unveils Game-Changing Nationwide TV Commercial for Adia Vita: A New Era in Regenerative Medicine
Winter Park, Florida--(Newsfile Corp. - June 24, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a rising name in the $15.1 billion global stem cell market, today ignited a revolution with the launch of its electrifying nationwide TV commercial for Adia Vita. Utilizing the innovative technology platform MNTN (NYSE: MNTN), which...
Healthcare and Hospitals, Health
2025-06-24 8:44 AM EDT | Adia Nutrition Inc.
Hadley and Notal Vision Partner to Empower Patients with Vision Loss Through Education and Leading Technology
Winnetka, Illinois--(Newsfile Corp. - June 24, 2025) - Hadley, a leading nonprofit empowering people with vision loss to adapt and thrive, and Notal Vision, a pioneer in AI-driven home diagnostic tools and digital healthcare for retinal diseases, today announced a strategic partnership to bridge the gap between early detection, treatment...
Healthcare and Hospitals, Health
2025-06-24 8:00 AM EDT | Notal Vision
SOL Global Announces Board Changes and Strategic Focus on Crypto Innovation
Toronto, Ontario--(Newsfile Corp. - June 24, 2025) - SOL Global Investments Corp. (CSE: SOL) (FSE: 9SB) ("SOL Global" or the "Company"), one of the first publicly traded companies focused on institutional Solana investments, today announces changes to its Board of Directors as part of a broader strategic shift toward digital...
Healthcare and Hospitals, Pharmaceuticals
2025-06-24 8:00 AM EDT | SOL Global Investments Corp.
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Marlborough, Massachusetts--(Newsfile Corp. - June 24, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will present an update...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-06-24 7:45 AM EDT | Phio Pharmaceuticals Corp.
Cosmo to Unveil First-of-its-Kind Clinical Study on the Use of GI Genius(TM) with Apple Vision Pro at Rush University Medical Center
Dublin, Ireland--(Newsfile Corp. - June 24, 2025) - Cosmo Pharmaceuticals N.V. (“Cosmo”) today announced that in July 2025, it will initiate their first usability study of a medical device software application connecting the Medtronic GI Genius™ intelligent endoscopy module,...
Healthcare and Hospitals, Health
2025-06-24 1:06 AM EDT | Cosmo Pharmaceuticals N.V.
LevelJump Announces 2025 First Quarter Results; Anticipates Revocation of Cease Trade Order
Toronto, Ontario--(Newsfile Corp. - June 23, 2025) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") is pleased to announce its financial results for the three months ended March 31, 2025.Financial and Operational HighlightsRevenues were $4.58 million in the first quarter of 2025 compared to $4.06 million in the same period...
Healthcare and Hospitals, Health
2025-06-23 11:50 AM EDT | LevelJump Healthcare Corp.
IR-MED Reports Positive Interim Results from U.S. Clinical Study of PressureSafe(TM) for Pressure Injury Assessment Across Diverse Skin Tones
PressureSafe™, IR-MED's lead product, demonstrated 94% sensitivity in assessing tissue at risk for pressure injuries prior to visible skin breakdownTechnology addresses longstanding disparities in skin assessment, particularly in patients with darker skin tonesResults presented at HCA Healthcare & Galen College of Nursing Research Day
Technology, Biotechnology, Healthcare and Hospitals, Health
2025-06-23 8:30 AM EDT | IR-MED, Inc.
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2025 Financial Results on July 1, 2025
Northvale, Northvale, New Jersey--(Newsfile Corp. - June 23, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, announced today that it would release its 2025 year-end financial results on Monday, June 30, 2025. Elite's management will host a live conference...
Healthcare and Hospitals, Pharmaceuticals, Health
2025-06-23 7:00 AM EDT | Elite Pharmaceuticals, Inc.
LevelJump Announces 2024 Financial Results
Toronto, Ontario--(Newsfile Corp. - June 20, 2025) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce its financial results for the year ended December 31, 2024.Financial and Operational HighlightsRevenues were $17.7 million in 2024 compared to $12.6 million in revenues for 2023, a year over year...
Healthcare and Hospitals, Health
2025-06-20 4:17 PM EDT | LevelJump Healthcare Corp.
Timing Is Everything - Adia Nutrition Inc. Celebrates Florida's SB 1768 with Open Invitations to Adia Med Clinic
Winter Park, Florida--(Newsfile Corp. - June 19, 2025) - Adia Nutrition Inc., (OTCQB: ADIA) a rising leader in the $15.1 billion global stem cell industry, enthusiastically welcomes Florida's Senate Bill 1768. Signed into law last month and effective July 1, 2025, this transformative legislation permits physicians to offer stem cell...
Healthcare and Hospitals, Health
2025-06-19 10:00 AM EDT | Adia Nutrition Inc.
NervGen Announces Appointment of Randall Kaye, MD to Chief Medical Advisor Role
Vancouver, British Columbia--(Newsfile Corp. - June 18, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing neuroreparative therapeutics, today announced the appointment of Randall Kaye, MD, to the role of Chief Medical Advisor. Dr. Kaye, a current member of NervGen's Board of Directors...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-06-18 7:30 AM EDT | NervGen Pharma Corp.